jrnls.org logo
Submit

BROWSE ALL JOURNALS

SEE ALL 19 JOURNALS
Biology, Engineering, Medicine and Science ReportsNOW IN
Article

Efficacy of Sucralfate in Reflux Disease in comparison to H2 – Receptor Antagonist: A Meta-Analysis of Randomized Trials

Renesh Bedre1, Utkarsh Raj2, Pritish Varadwaj2★★ Corresponding author

  1. 1Louisiana State University, Agricultural Center, Baton Rouge, LA.
  2. 2Department of Bioinformatics, Indian Institute of Information Technology, Allahabad, INDIA.

CORRESPONDENCE

Pritish Varadwaj

Department of Bioinformatics, Indian Institute of Information Technology, Allahabad, INDIA.

pritish@iiita.ac.in

Received: 03-09-2015; Revised: 18-06-2016; Accepted: 22-06-2016.

Volume 2, Issue 1 · pp. 18–22 · PUBLISHED · DOI: 10.5530/BEMS.2016.1.4

View on BEMSR original site ↗

ABSTRACT

Background and Aim:Reflux esophagitis is characterized by the erosions of esophagus due to gastric acids. H2 -Recptor antagonists are considered as effective therapy. We compared sucralfate with H2 -receptor antagonist for treatment of reflux esophagitis. Methods:Seven studies are selected from different databases (PUBMED, MEDLINE, COCHRANE LIBRARY, CINAHL etc.) comparing the treatment of sucralfate with H2 -receptor antagonists (cimetidine and ranitidine). All studies selected are randomized controlled clinical trials. We applied inclusion and exclusion criteria for selection of studies. We also checked for heterogeneity and publication bias. We calculated odds ratio and 95% confidence interval for each study. We searched for national library of medicine’s clinical trial registry for any unpublished data. Results: Seven studies consisting of 319 patients finally selected for meta-analysis. We evaluated confidence interval and odds ratio for each study. None of the study show statistical significant result (p>0.05). The overall effect obtained by combining studies shows no statistical significant result (OR= 1.357, 95% CI=0.834 to 2.206, P-value=0.219, I2 =0) between sucralfate and H2 -recptor antagonist. There is no heterogeneity among the studies (I2 =0, χ2 =4.8). Conclusion:We can conclude that sucralfate is an effective alternate for treatment of reflux disease.

KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Bedre, R., Raj, U., & Varadwaj, P. (). Efficacy of Sucralfate in Reflux Disease in comparison to H2 – Receptor Antagonist: A Meta-Analysis of Randomized Trials. Biology, Engineering, Medicine and Science Reports, 2(1), 18–22. https://doi.org/10.5530/BEMS.2016.1.4